Show simple item record

Androgen stimulated chemotherapy in the dunning R-3327 prostatic adenocarcinoma

dc.contributor.authorGrossman, H. Bartonen_US
dc.contributor.authorWhitmore, Willet F.en_US
dc.contributor.authorKleinert, Edward L.en_US
dc.contributor.authorLesser, Martin L.en_US
dc.contributor.authorHerr, Harry W.en_US
dc.date.accessioned2006-09-11T18:04:30Z
dc.date.available2006-09-11T18:04:30Z
dc.date.issued1981-10en_US
dc.identifier.citationGrossman, H. Barton; Kleinert, Edward L.; Lesser, Martin L.; Herr, Harry W.; Whitmore, Willet F.; (1981). "Androgen stimulated chemotherapy in the dunning R-3327 prostatic adenocarcinoma." Urological Research 9(5): 237-240. <http://hdl.handle.net/2027.42/46680>en_US
dc.identifier.issn0300-5623en_US
dc.identifier.issn1434-0879en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/46680
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7303347&dopt=citationen_US
dc.description.abstractThis study was undertaken to determine whether hormonal stimulation followed by chemotherapy with a cell-cycle specific agent would improve the effectiveness of the chemotherapy in a prostatic adenocarcinoma model.en_US
dc.format.extent287630 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlagen_US
dc.subject.otherChemotherapyen_US
dc.subject.otherMedical Biochemistryen_US
dc.subject.otherMedicine & Public Healthen_US
dc.subject.otherR-3327 Prostatic Adenocarcinomaen_US
dc.subject.otherHormonal Stimulationen_US
dc.subject.otherNephrologyen_US
dc.subject.otherUrology/Andrologyen_US
dc.titleAndrogen stimulated chemotherapy in the dunning R-3327 prostatic adenocarcinomaen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumSection of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA; Section of Urology, University of Michigan Medical Center, 1405 East Ann Street, Box 03, 48109, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationotherSection of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USAen_US
dc.contributor.affiliationotherBiostatistics Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, USAen_US
dc.contributor.affiliationotherSection of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USAen_US
dc.contributor.affiliationotherSection of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid7303347en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/46680/1/240_2004_Article_BF00256893.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00256893en_US
dc.identifier.sourceUrological Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.